Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1953 1
1954 1
1955 2
1956 1
1958 1
1959 2
1963 1
1964 5
1965 8
1966 7
1967 20
1968 31
1969 33
1970 23
1971 44
1972 46
1973 40
1974 45
1975 38
1976 34
1977 34
1978 34
1979 40
1980 42
1981 43
1982 60
1983 56
1984 71
1985 55
1986 67
1987 58
1988 46
1989 59
1990 63
1991 71
1992 71
1993 71
1994 85
1995 87
1996 80
1997 79
1998 114
1999 112
2000 122
2001 124
2002 105
2003 126
2004 166
2005 178
2006 206
2007 237
2008 241
2009 291
2010 260
2011 308
2012 278
2013 279
2014 328
2015 377
2016 455
2017 470
2018 458
2019 487
2020 562
2021 553
2022 537
2023 466
2024 158

Text availability

Article attribute

Article type

Publication date

Search Results

8,581 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Disorder of eye due to diabetes mellitus"
Page 1
Association Between Diabetes, Diabetic Retinopathy, and Glaucoma.
Li Y, Mitchell W, Elze T, Zebardast N. Li Y, et al. Curr Diab Rep. 2021 Sep 8;21(10):38. doi: 10.1007/s11892-021-01404-5. Curr Diab Rep. 2021. PMID: 34495413 Review.
We review evidence supporting and refuting this association and explore mechanistic pathological and treatment relationships linking these diseases. RECENT FINDINGS: While studies have shown diabetes/DR may increase the risk for glaucoma, this remains inconsistently …
We review evidence supporting and refuting this association and explore mechanistic pathological and treatment relationships linking these …
Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group.
[No authors listed] [No authors listed] Diabetes Care. 1987 Jan-Feb;10(1):1-19. doi: 10.2337/diacare.10.1.1. Diabetes Care. 1987. PMID: 2882967 Clinical Trial.
The Diabetes Control and Complications Trial (DCCT) is a multicenter, randomized, clinical study designed to determine whether an intensive treatment regimen directed at maintaining blood glucose concentrations as close to normal as possible will affec …
The Diabetes Control and Complications Trial (DCCT) is a multicenter, randomized, clinical study designed to det …
Optical coherence tomography angiography in diabetic retinopathy.
Waheed NK, Rosen RB, Jia Y, Munk MR, Huang D, Fawzi A, Chong V, Nguyen QD, Sepah Y, Pearce E. Waheed NK, et al. Prog Retin Eye Res. 2023 Nov;97:101206. doi: 10.1016/j.preteyeres.2023.101206. Epub 2023 Jul 26. Prog Retin Eye Res. 2023. PMID: 37499857 Free article. Review.
Numerous studies have confirmed that OCTA can identify early evidence of microvascular changes and provide quantitative assessment of the extent of diseases such as DR and its complications. A number of informative OCTA metrics could be used to assess DR in clinical …
Numerous studies have confirmed that OCTA can identify early evidence of microvascular changes and provide quantitative assessment of the ex …
Diabetic retinopathy in pregnancy - A review.
Chandrasekaran PR, Madanagopalan VG, Narayanan R. Chandrasekaran PR, et al. Indian J Ophthalmol. 2021 Nov;69(11):3015-3025. doi: 10.4103/ijo.IJO_1377_21. Indian J Ophthalmol. 2021. PMID: 34708737 Free PMC article. Review.
Diabetes and gestational diabetes (GD) are areas of concern worldwide. GD can eventually lead to serious development of diabetic retinopathy (DR) during pregnancy or worsening of an already existing DR. GD confers future risk of diabetes, both in the mother a …
Diabetes and gestational diabetes (GD) are areas of concern worldwide. GD can eventually lead to serious development of diabet …
GLP-1 receptor agonists and diabetic retinopathy: A meta-analysis of randomized clinical trials.
Kapoor I, Sarvepalli SM, D'Alessio D, Grewal DS, Hadziahmetovic M. Kapoor I, et al. Surv Ophthalmol. 2023 Nov-Dec;68(6):1071-1083. doi: 10.1016/j.survophthal.2023.07.002. Epub 2023 Jul 16. Surv Ophthalmol. 2023. PMID: 37454782 Review.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are used to treat type 2 diabetes mellitus. Recent research suggests that GLP-1 RAs may influence diabetic retinopathy (DR). ...Demographic analysis revealed significant differences between GLP-1 RA and comparato …
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are used to treat type 2 diabetes mellitus. Recent research suggests tha …
New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy.
Saw M, Wong VW, Ho IV, Liew G. Saw M, et al. Eye (Lond). 2019 Dec;33(12):1842-1851. doi: 10.1038/s41433-019-0494-z. Epub 2019 Jun 21. Eye (Lond). 2019. PMID: 31227789 Free PMC article. Review.
There has been an increase in the range of non-insulin anti-hyperglycaemic agents used to treat type 2 diabetes. With the globally rising rates of type 2 diabetes and complications such as diabetic retinopathy, it is important for ophthalmologists to be aware of the …
There has been an increase in the range of non-insulin anti-hyperglycaemic agents used to treat type 2 diabetes. With the globally ri …
Diabetic macular oedema.
Tan GS, Cheung N, Simó R, Cheung GC, Wong TY. Tan GS, et al. Lancet Diabetes Endocrinol. 2017 Feb;5(2):143-155. doi: 10.1016/S2213-8587(16)30052-3. Epub 2016 Aug 3. Lancet Diabetes Endocrinol. 2017. PMID: 27496796 Review.
Diabetic macular oedema, characterised by exudative fluid accumulation in the macula, is the most common form of sight-threatening retinopathy in people with diabetes. It affects one in 15 people with diabetes resulting in more than 20 million cases worldwide. Few e …
Diabetic macular oedema, characterised by exudative fluid accumulation in the macula, is the most common form of sight-threatening retinopat …
Semaglutide and Diabetic Retinopathy Risk in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials.
Wang F, Mao Y, Wang H, Liu Y, Huang P. Wang F, et al. Clin Drug Investig. 2022 Jan;42(1):17-28. doi: 10.1007/s40261-021-01110-w. Epub 2021 Dec 11. Clin Drug Investig. 2022. PMID: 34894326
BACKGROUND: Semaglutide is a recently approved glucagon-like peptide-1 receptor agonist used to treat patients with type 2 diabetes mellitus (T2DM). The SUSTAIN 6 trial found a significantly higher rate of retinopathy complications in the semaglutide-treated …
BACKGROUND: Semaglutide is a recently approved glucagon-like peptide-1 receptor agonist used to treat patients with type 2 diabetes …
Frontiers in diabetic retinal disease.
Torm MEW, Dorweiler TF, Fickweiler W, Levine SR, Fort PE, Sun JK, Gardner TW. Torm MEW, et al. J Diabetes Complications. 2023 Feb;37(2):108386. doi: 10.1016/j.jdiacomp.2022.108386. Epub 2022 Dec 21. J Diabetes Complications. 2023. PMID: 36608490 Free PMC article. Review.
Recent advances in retinal imaging methods for patients with diabetes allow a more precise and granular characterization of the different stages of DRD than is provided by the classic Diabetic Retinopathy Severity Scale based on fundus photographs. In addition, recent c …
Recent advances in retinal imaging methods for patients with diabetes allow a more precise and granular characterization of the diffe …
8,581 results